Publicacions
-
Esteller-Cucala P, Maceda I, Børglum AD, Demontis D, Faraone SV, Cormand B and Lao O.
Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples.
SCIENTIFIC REPORTS . 10(1): 8622-8622. Nº de cites: 13
-
Fernandez-Castillo N, Gan G, van Donkelaar MMJ, Vaht M, Weber H, Retz W, Meyer-Lindenberg A, Franke B, Harro J, Reif A, Faraone SV and Cormand B.
RBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior.
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 30: 44-55. Nº de cites: 36
-
.
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders.
Cell . 179(7): 1469. Nº de cites: 735
-
Zhang-James Y, Fernandez-Castillo N, Hess JL, Malki K, Glatt SJ, Cormand B and Faraone SV.
An integrated analysis of genes and functional pathways for aggression in human and rodent models.
MOLECULAR PSYCHIATRY . 24(11): 1655-1667. Nº de cites: 55
-
Pineda L, Shivalikanjli A, Cabana-Domínguez J, Demontis D, Rajagopal VM, Børglum AD, Faraone SV, Cormand B and Fernandez-Castillo N.
Exploring genetic variation that influences brain methylation in attention-deficit/hyperactivity disorder
TRANSLATIONAL PSYCHIATRY . 9(1): 242-242. Nº de cites: 20
-
Torrico B, Shaw AD, Mosca R, Vivó-Luque N, Hervás A, Fernandez-Castillo N, Aloy P, Bayés M, Fullerton JM, Cormand B and Toma C.
Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE . 44(5): 350-359. Nº de cites: 17
-
Cabana-Domínguez J, Shivalikanjli A, Fernandez-Castillo N and Cormand B.
Genome-wide association meta-analysis of cocaine dependence: Shared genetics with comorbid conditions
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY . 94: 109667-109667. Nº de cites: 39
-
Chelban V, Wilson MP, Warman Chardon J, Vandrovcova J, Zanetti MN, Zamba-Papanicolaou E, Efthymiou S, Pope S, Conte MR, Abis G, Liu YT, Tribollet E, Haridy NA, Botía JA, Ryten M, Nicolaou P, Minaidou A, Christodoulou K, Kernohan KD, Eaton A, Osmond M, Ito Y, Bourque P, Jepson JEC, Bello O, Bremner F, Cordivari C, Reilly MM, Foiani M, Heslegrave A, Zetterberg H, Heales SJR, Wood NW, Rothman JE, Boycott KM, Mills PB, Clayton PT, Houlden H and Care4Rare Canada Consortium and the SYNaPS Study Group.
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation.
ANNALS OF NEUROLOGY . 86(2): 225-240. Nº de cites: 66
-
Salpietro V, Malintan NT, Llano-Rivas I, Spaeth CG, Efthymiou S, Striano P, Vandrovcova J, Cutrupi MC, Chimenz R, David E, Di Rosa G, Marce-Grau A, Raspall-Chaure M, Martin-Hernandez E, Zara F, Minetti C, Deciphering Developmental Disorders Study, SYNAPS Study Group, Bello OD, De Zorzi R, Fortuna S, Dauber A, Alkhawaja M, Sultan T, Mankad K, Vitobello A, Thomas Q, Mau-Them FT, Faivre L, Martinez-Azorin F, Prada CE, Macaya A, Kullmann DM, Rothman JE, Krishnakumar SS and Houlden H.
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment.
AMERICAN JOURNAL OF HUMAN GENETICS . 104(4): 721-730. Nº de cites: 80
-
Arcos-Burgos M, Vélez JI, Martinez AF, Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, Richarte V, Roncero C, Cormand B, Fernandez-Castillo N, Casas M, Lopera F, Pineda DA, Palacio JD, Acosta-López JE, Cervantes-Henriquez ML, Sánchez-Rojas MG, Puentes-Rozo PJ, Molina BSG, MTA Cooperative Group, Boden MT, Wallis D, Lidbury B, Newman S, Easteal S, Swanson J, Patel H, Volkow N, Acosta MT, Castellanos FX, de Leon J, Mastronardi CA and Muenke M.
ADGRL3 (LPHN3) variants predict substance use disorder
TRANSLATIONAL PSYCHIATRY . 9(1): 42-42. Nº de cites: 28